Open AccessSerum Levels of ITGBL1 as an Early Diagnostic Biomarker for Hepatocellular Carcinoma with Hepatitis B Virus Infection
Author(s) -
Fei Ye,
Wei Huang,
Yuan Xue,
Erjiang Tang,
Mingjie Wang,
Fengchun Shi,
Dong Wei,
Yue Han,
Peizhan Chen,
Xinxin Zhang,
Demin Yu
Publication year - 2021
Publication title -
journal of hepatocellular carcinoma
Language(s) - English
Resource type - Journals
ISSN - 2253-5969
DOI - 10.2147/jhc.s306966
Subject(s) - hepatocellular carcinoma , medicine , hepatitis b virus , gastroenterology , cirrhosis , receiver operating characteristic , stage (stratigraphy) , hepatitis b , biomarker , entecavir , cohort , area under the curve , immunology , virus , lamivudine , paleontology , biochemistry , chemistry , biology
Early diagnostic biomarkers of hepatocellular carcinoma (HCC) are needed to distinguish hepatitis B virus (HBV) associated HCC (HBV-HCC) patients from at-risk patients. We assessed the diagnostic values of serum Integrin beta-like 1 (ITGBL1) for early-stage HBV-HCC.